Figure | Data | Comparison (Group I vs Group II) | Mean ± SEM, n (Group I vs Group II) | Type of test, p | Effect size [95% CI], p |
---|---|---|---|---|---|
5C | Amplitude eAMPA | APV vs gabazine + APV | 36.10 ± 5.25 pA, n = 10 vs 82.04 ± 15.23 pA, n = 10 | Mann–Whitney U, 0.034 | 45.9 [18.5, 78.0], 0.01 |
5C | PPR | APV vs gabazine + APV | 1.33 ± 0.12, n = 10 vs 1.27 ± 0.11, n = 10 | Independent-samples t test, 0.706 | −0.0615 [−0.372, 0.223], 0.702 |
6B | Amplitude eGABA | APV vs gabazine + APV | 48.34 ± 7.17 pA, n = 16 vs 69.32 ± 8.28 pA, n = 20 | Independent-samples t test, 0.071 | 21 [0.295, 42.1], 0.0726 |
6B | PPR | APV vs gabazine + APV | 1.29 ± 0.11, n = 18 vs 1.21 ± 0.14, n = 20 | Mann–Whitney U, 0.198 | −0.0818 [−0.372, 0.292], 0.648 |
↵aThe numbers of cells (n) for each group are shown, along with significance for each comparison. Effect size represents the mean difference between APV and gabazine + APV.